May 24, 2021
2 min watch
Save
VIDEO: Eysuvis positioned as short-term solution for dry eye flares
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
WAILEA, Hawaii — In this video from Hawaiian Eye 2021, Todd Bazemore, chief operating officer at Kala Pharmaceuticals, offers a company update, including the recent approval of Eysuvis (loteprednol) for dry eye disease signs and symptoms.
Published by:
Sources/Disclosures
Collapse
Source:
Todd Bazemore
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.